Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Integrative Chinese and Western Medicine for DOR-Associated Infertility
NCT07296614Phase 3Not yet recruiting
- Sponsor
- Peking Union Medical College Hospital
- Start
- Dec 2025
- Primary completion
- Jul 2028
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of Bushen Tongzhi Formula in Diminished Ovarian Reserve (DOR), infertility, sponsored by Peking Union Medical College Hospital. Planned start Dec 2025; status: not yet recruiting.
02
Drugs
Bushen Tongzhi Formula
03
Conditions
Diminished Ovarian Reserve (DOR)infertility
Beyond the preview
Go deeper on NCT07296614.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT07296614.